- Home
- UNCY vs CPHC Comparison
UNCY vs CPHC Comparison
Compare UNCY & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- CPHC
- Stock Information
- Founded
- UNCY 2016
- CPHC 1994
- Country
- UNCY United States
- CPHC United States
- Employees
- UNCY N/A
- CPHC N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- CPHC Services-Misc. Amusement & Recreation
- Sector
- UNCY Health Care
- CPHC Consumer Discretionary
- Exchange
- UNCY Nasdaq
- CPHC Nasdaq
- Market Cap
- UNCY 91.0M
- CPHC 89.8M
- IPO Year
- UNCY 2021
- CPHC 1994
- Fundamental
- Price
- UNCY $4.55
- CPHC $18.51
- Analyst Decision
- UNCY Strong Buy
- CPHC
- Analyst Count
- UNCY 4
- CPHC 0
- Target Price
- UNCY $63.75
- CPHC N/A
- AVG Volume (30 Days)
- UNCY 1.5M
- CPHC 11.7K
- Earning Date
- UNCY 08-13-2025
- CPHC 08-07-2025
- Dividend Yield
- UNCY N/A
- CPHC 1.51%
- EPS Growth
- UNCY N/A
- CPHC N/A
- EPS
- UNCY N/A
- CPHC 0.16
- Revenue
- UNCY N/A
- CPHC $60,605,931.00
- Revenue This Year
- UNCY N/A
- CPHC N/A
- Revenue Next Year
- UNCY $1,458.53
- CPHC N/A
- P/E Ratio
- UNCY N/A
- CPHC $114.87
- Revenue Growth
- UNCY N/A
- CPHC N/A
- 52 Week Low
- UNCY $2.02
- CPHC $16.75
- 52 Week High
- UNCY $11.00
- CPHC $22.93
- Technical
- Relative Strength Index (RSI)
- UNCY 39.53
- CPHC 51.72
- Support Level
- UNCY $4.76
- CPHC $18.80
- Resistance Level
- UNCY $7.15
- CPHC $21.61
- Average True Range (ATR)
- UNCY 0.97
- CPHC 0.91
- MACD
- UNCY -0.28
- CPHC 0.04
- Stochastic Oscillator
- UNCY 7.37
- CPHC 34.18
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.